Evaluating the Efficacy and Safety of Zonisamide in the Treatment of Partial Seizures
- First Posted Date
- 2006-05-18
- Last Posted Date
- 2014-08-15
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 240
- Registration Number
- NCT00327717
- Locations
- 🇨🇳
Peking Union Hospital, Beijing, Beijing, China
🇨🇳Peking Union Medical College Hospital, Beijing, Beijing, China
🇨🇳The First Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing, China
Safety and Tolerability of E5555 and Its Effects on Markers of Intravascular Inflammation in Subjects With Coronary Artery Disease
- First Posted Date
- 2006-04-07
- Last Posted Date
- 2016-12-05
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 720
- Registration Number
- NCT00312052
- Locations
- 🇺🇸
Florida Research Network, Gainesville, Florida, United States
🇺🇸Great Lakes Heart Center of Alpena, Alpena, Michigan, United States
A Phase II Study of the Safety and Efficacy of E7820 Plus Cetuximab in Colorectal Cancer, Preceded by a Run-in Study in Advanced Solid Tumors
- Conditions
- Advanced Colorectal Cancer
- Interventions
- Drug: E7820 plus cetuximab
- First Posted Date
- 2006-03-31
- Last Posted Date
- 2017-09-14
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 41
- Registration Number
- NCT00309179
An Effectiveness and Safety Study of AQUAVAN® Injection (Fospropofol Disodium) for Sedation During Flexible Bronchoscopy
- Conditions
- BronchoscopyAnesthesia
- First Posted Date
- 2006-03-24
- Last Posted Date
- 2008-11-07
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 250
- Registration Number
- NCT00306722
- Locations
- 🇺🇸
Pulmonary Associates of Mobile, PC, Mobile, Alabama, United States
🇺🇸Saddleback Memorial Medical Center, Laguna Hills, California, United States
🇺🇸Hurley Medical Center, Flint, Michigan, United States
Safety and Efficacy Study for the Prevention of Nausea and Vomiting in Multiple Myeloma Patients Receiving Stem Cell Transplantation.
- First Posted Date
- 2006-03-24
- Last Posted Date
- 2016-12-05
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 75
- Registration Number
- NCT00306735
- Locations
- 🇺🇸
Indiana Blood and Marrow Transplantation, Beech Grove, Indiana, United States
🇺🇸Cornell Medical Center, New York, New York, United States
🇺🇸Wake Forest Medical Center, Winston-Salem, North Carolina, United States
The Evaluation of the Efficacy and Safety of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment (MCI)
- First Posted Date
- 2006-02-17
- Last Posted Date
- 2011-04-01
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 821
- Registration Number
- NCT00293176
A Study for Evaluating the Efficacy and Safety of Zonisamide and Lamotrigine (Lamictal) for Subjects With Refractory Simple Partial, Complex Partial or Partial With Secondary Generalized Seizures
- First Posted Date
- 2006-02-16
- Last Posted Date
- 2013-05-20
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 64
- Registration Number
- NCT00292461
- Locations
- 🇨🇳
National Cheng Kung University Hospital, Tainan, Taiwan, China
🇨🇳Chang-Gung Memorial Hospital (CGMH), Taipei, Taiwan, China
🇨🇳Changhua Christian Hospital, Changhua, Taiwan, China
A Clinical Trial of Decitabine in Patients With Myelodysplastic Syndrome
- First Posted Date
- 2006-01-26
- Last Posted Date
- 2015-10-28
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 41
- Registration Number
- NCT00282399
- Locations
- 🇺🇸
H Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States
🇺🇸Albert Einstein College of Medicine, Bronx, New York, United States
🇺🇸University of Arizona Cancer Center, Tucson, Arizona, United States
An Open Label Phase I Dose Escalation Study of E7080 Administered to Patients With Solid Tumors
- First Posted Date
- 2006-01-23
- Last Posted Date
- 2016-10-07
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 27
- Registration Number
- NCT00280397
Study Investigating the Effect of E7337 on Tumor Like Lesions in Computed Tomography (CT) of the Liver
- Conditions
- Lesions of the Liver
- First Posted Date
- 2006-01-23
- Last Posted Date
- 2010-01-29
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 192
- Registration Number
- NCT00280410